In the latest episode of DeviceTalks AI, President and CEO of Asensus Surgical, Anthony Fernando walks us through the significant differences between augmented intelligence and artificial intelligence and how Asensus is leveraging these technologies to improve surgical outcomes. Anthony discusses the inception and evolution of Asensus Surgical's innovative robotic platforms, including the Senhance and Luna systems, and delves into the core advantages of using augmented over artificial intelligence to aid surgeons. He describes the Intelligent Surgical Unit (ISU), its unique regulatory pathway, and its pivotal role in providing the surgeon with real-time context, ensuring higher precision, consistency, and reduced cognitive fatigue during surgeries.

To get the full story on the Karl Storz acquisition of Asensus Surgical, visit: https://www.massdevice.com/asensus-to-be-acquired-karl-storz/

In the second part of the episode, GM of Health AI at Amazon Web Services (AWS), Tehsin Syed, talks about the intersection of healthcare, life sciences, and AI and how AWS is helping healthcare and life sciences organizations leverage AI without the need for extensive technical expertise. Tehsin highlights AWS services like Comprehend Medical and HealthScribe, which are designed to simplify the processing and analysis of healthcare data. He also discusses the potential of generative AI in accelerating drug discovery, clinical trial optimization, and personalized medicine.

Make sure to check out DeviceTalks Spotlight, a growing library of insights and expertise from the best in the medical device business: https://gateway.on24.com/wcc/experience/elitewtwhmedia/2927718/4598161/devicetalks-spotlight

Please subscribe to DeviceTalks AI on all major podcast channels and subscribe to DeviceTalks on YouTube to ensure you never miss an episode.

Thank you for listening to DeviceTalks AI!

Ver todos los episodios